Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation

NCT: NCT05556902 · RECRUITING

NCT IDNCT05556902
StatusRECRUITING
Start Date2022-08-02
Completion2030-05-01
SponsorUniversity of Alabama at Birmingham (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study in patients undergoing routine care epidural spinal cord stimulation (SCS) is to determine 1) whether SCS reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension, 2) whether higher baseline BP (i.e., hypertension) predicts reductions in pain following SCS, and finally 3) whether different SCS waveforms elicits stimulus-evoked compound action potentials (ECAPs) in spinal cord and at the cortex (electroencephalography, and magnetoenchphalography).

Frequently Asked Questions

What is Therapeutic Mechanisms of Epidural Spinal Cord Stimulation?

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation is a clinical trial registered under NCT05556902. Current status: RECRUITING.

What is the status of NCT05556902?

The current status of NCT05556902 (Therapeutic Mechanisms of Epidural Spinal Cord Stimulation) is: RECRUITING.

When did Therapeutic Mechanisms of Epidural Spinal Cord Stimulation start?

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation started on 2022-08-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.